financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
May 1, 2024
May 2 (Reuters) - BioCatch: * PERMIRA TO ACQUIRE MAJORITY POSITION IN BIOCATCH AT $1.3BN VALUATION * BIOCATCH - UNDER THE TERMS OF THE AGREEMENT, THE FUND WILL ACQUIRE A MAJORITY STAKE IN BIOCATCH * BIOCATCH - TRANSACTION IS EXPECTED TO ACCELERATE THE COMPANY'S GLOBAL EXPANSION Source text for Eikon: Further company coverage: ...
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
May 1, 2024
* UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro * Competition for customers raises concerns over patient aftercare * Users of the drugs need medical supervision By Ludwig Burger May 2 (Reuters) - Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply...
StanChart Q1 profit beats estimates as income boost outweighs China woes
StanChart Q1 profit beats estimates as income boost outweighs China woes
May 1, 2024
HONG KONG/LONDON (Reuters) -Standard Chartered PLC ( SCBFF ) beat forecasts on Thursday with a 5.5% rise in its first-quarter pretax profit, as the income boost from higher interest rates and a robust performance from its markets trading business offset a surge in credit losses. The bank, which makes the bulk of its revenue and profits in Asia, saw its...
Standard Chartered Q1 profit rises 5.5%, beats estimates
Standard Chartered Q1 profit rises 5.5%, beats estimates
May 1, 2024
HONG KONG, May 2 (Reuters) - Standard Chartered PLC ( SCBFF ) posted on Thursday a 5.5% rise in its first-quarter pretax profit, beating estimates, as higher interest rates bolstered earnings at the emerging markets-focused lender. StanChart, which earns most of its revenue in Asia, said statutory pretax profit in the quarter was $1.91 billion. That compared with $1.81 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved